A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from ecuadorian women

Journal of Medical Virology

Volumn 80, Issue 11, 2008, Pages 1959-1965

  Tornesello, Maria Lina ^a   Buonaguro, Luigi ^a   Izzo, Sergio ^b   Lopez, Guillermo ^c   Vega, Ximena ^c   Reyes, Claudio Francisco Maldonado ^c   Buonaguro, Franco Maria ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Azienda Ospedaliera di Caserta   (Italy)

^c Instituto de Colposcopía e Histeroscopía   (Ecuador)

Author keywords

Cervical neoplasia; Ecuador; HPV genotypes

Indexed keywords

ADULT; ARTICLE; ECUADOR; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 81; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PILOT STUDY; PREVALENCE; SEQUENCE ANALYSIS; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; WART VIRUS;

ADULT; DNA, VIRAL; ECUADOR; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 54749134689     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21317     Document Type: Article

References (52)

1. Alencar TR, Cerqueira DM, da Cruz MR, Wyant PS, Ramalho ED, Martins CR. 2007. New HPV-16 European and non-European variants in Central Brazil. Virus Genes 35:1-4.
2. Almonte M, Ferreccio C, Winkler JL, Cuzick J, Tsu V, Robles S, Takahashi R, Sasieni P. 2007. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 121:796-802.
3. Arrossi S, Sankaranarayanan R, Parkin DM. 2003. Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex 45:S306-S314.
4. Bernard HU, Calleja-Macias IE, Dunn ST. 2006. Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int J Cancer 118:1071-1076.
5. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: A case-control study. J Natl Cancer Inst 93:1325-1330.
6. Bray F, Sankila R, Ferlay J, Parkin DM. 2002. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99-166.
7. Buonaguro FM, Tornesello ML, Beth-Giraldo E, Hatzakis A, Mueller N, Downing R, Biryamwaho B, Sempala SD, Giraldo G. 1996. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65:25-28.
8. Buonaguro FM, Tornesello ML, Salatiello I, Okong P, Buonaguro L, Beth-Giraldo E, Biryahwaho B, Sempala SD, Giraldo G. 2000. The Uganda study on HPV variants and genital cancers. J Clin Virol 19:31-41.
9. Calleja-Macias IE, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, Barrera-Saldaña HA, Cubie HA, Cuschieri K, Villa LL, Bernard HU. 2004. Genomic diversity of human papillomavirus-16, 18, 31 and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 319:315-323.
10. Castellsague X, Munoz N. 2003. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20-28.
11. Cerqueira DM, de S Moraes D, Camara GN, Amaral FA, Oyama CN, dos Santos MQ, Martins CR. 2007. High HPV genetic diversity in women infected with HIV-1 in Brazil. Arch Virol 152:75-83.
12. Chan SY, Ho L, Ong CK, Chow V, Drescher B, Durst M, ter Meulen J, Villa L, Luande J, Mgaya HN. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 66:2057-2066.
13. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105.
14. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14:1157-1164.
15. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El GF. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204.
16. del Refugio Gonzalez-Losa M, Laviada Mier y Teran M, Puerto-Solis M, Garci-Carranca A. 2004. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol 29:95-98.
17. Fredricks DN, Relman DA. 1999. Paraffin removal from tissue sections for digestion and PCR analysis. Biotechniques 26:198-200.
18. Gonzalez-Losa MR, Rosado-Lopez I, Valdez-Gonzalez N, Puerto-Solis M. 2004. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J Clin Virol 29:202-205.
19. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 1.6 and 18: Follow-up from a randomised control trial. Lancet 367:1247-1255.
20. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, et al. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
21. Hiller T, Poppelreuther S, Stubenrauch F, Iftner T. 2006. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol Biomarkers Prev 15:1262-1267.
22. Hindryckx P, Garcia A, Claeys P, Gonzalez C, Velasquez R, Bogers J, Van RL, Cuvelier CA. 2006. Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix. Sex Transm Infect 82:334-336.
23. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120.
24. Lorenzato F, Ho L, Terry G, Singer A, Santos LC, De Lucena BR, Lubambo T. 2000. The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 10:143-150.
25. Molano M, van den Brule AJ, Posso H, Weiderpass E, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N. 2002. Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women. Br J Cancer 87:1417-1421.
26. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
27. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24(S3):S1-S10.
28. Nucleotide-nucleotide BLAST. 2007. http://www.ncbi.nlm.nih.gov/blast/.
29. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
30. Picconi MA, Alonio LV, Sichero L, Mbayed V, Villa LL, Gronda J, Campos R, Teyssie A. 2003. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J Med Virol 69:546-552.
31. Pina-Sanchez P, Hernandez-Hernandez DM, Lopez-Romero R, Vazquez-Ortiz G, Perez-Plasencia C, Lizano-Soberon M, Gonzalez-Sanchez JL, Cruz-Talonia F, Salcedo M. 2006. Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions. Int J Gynecol Cancer 16:1041-1047.
32. Rattray C, Strickler HD, Escoffery C, Cranston B, Brown C, Manns A, Schiffman MH, Palefsky JM, Hanchard B, Blattner WA. 1996. Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients. J Infect Dis 173:718-721.
33. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
34. Seedorf K, Krämmer G, Dürst M, Suhai S, Röwekamp WG. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
35. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. 2007. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763-1768.
36. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121:621-632.
37. Tornesello ML, Buonaguro FM, Meglio A, Buonaguro L, Beth-Giraldo E, Giraldo G. 1997. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol 78:2199-2208.
38. Tornesello ML, Buonaguro FM, Buonaguro L, Salatiello I, Beth-Giraldo E, Giraldo G. 2000. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol 81:2969-2982.
39. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, et al. 2004. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74:117-126.
40. Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM. 2006. Prevalence of alpha-papillomavirus genotypes in cervical intraepithelial neoplasia and cervical cancer in the Italian population. J Med Virol 78:1663-1672.
41. Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM. 2007. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2:1.
42. Van de PY, De WR. 1993. TREECON: A software package for the construction and drawing of evolutionary trees. Comput Appl Biosci 9:177-182.
43. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968.
44. Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, Brown DR, Ferenczy A, Harper DM, et al. 2006. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine 24:5571-5583.
45. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
46. Winship PR. 1989. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res 17:1266.
47. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
48. Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee SK, Adam DE, Kiviat NB, Koutsky LA. 2002. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11:343-3351.
49. Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutsky LA. 2006. Human papillomavirus type 16 and 18 variants: Race-related distribution and persistence. J Natl Cancer Inst 98:1045-1052.
50. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB. 2007. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 16:4-10.
51. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69:7743-7753.
52. zur Hausen H. 1991. Human papillomaviruses in the pathogenesis of anogenital Cancer. Virology 184:9-13.